<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font17">for </span>
   <span class="font16">COVID- </span>
   <span class="font14">with </span>
   <span class="font13">[]. </span>
   <span class="font13">patients </span>
   <span class="font13">Phase </span>
   <span class="font12">Frame:Â </span>
   <span class="font12">TimeÂ </span>
   <span class="font12">are </span>
   <span class="font12">clinical </span>
   <span class="font12">The </span>
   <span class="font12">from </span>
   <span class="font12">that </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">treatment </span>
   <span class="font12">has </span>
   <span class="font12">day </span>
   <span class="font12">trial </span>
   <span class="font11">viral </span>
   <span class="font11">[], </span>
   <span class="font11">days </span>
   <span class="font11">NCT </span>
   <span class="font11">Label </span>
   <span class="font11">Randomized; </span>
   <span class="font11">its </span>
   <span class="font11">{background </span>
   <span class="font11">(). </span>
   <span class="font11">(NCT) </span>
   <span class="font11">Accessed </span>
   <span class="font11">coronavirus </span>
   <span class="font11">Experimental: </span>
   <span class="font11">after </span>
   <span class="font11">against </span>
   <span class="font11">Open </span>
   <span class="font11">was </span>
   <span class="font11">have </span>
   <span class="font11">vaccine </span>
   <span class="font11">been </span>
   <span class="font11">trials </span>
   <span class="font11">plasma </span>
   <span class="font11">which </span>
   <span class="font11">July </span>
   <span class="font11">drug </span>
   <span class="font11">margin </span>
   <span class="font11">COVID-. </span>
   <span class="font11">also </span>
   <span class="font11">respiratory </span>
   <span class="font11">{border-style </span>
   <span class="font11">(â‰¥) </span>
   <span class="font11">mortality </span>
   <span class="font11">per </span>
   <span class="font11">use </span>
   <span class="font10">currently </span>
   <span class="font10">px;} </span>
   <span class="font10">were </span>
   <span class="font10">will </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Patients </span>
   <span class="font10">dose </span>
   <span class="font10">group </span>
   <span class="font10">not </span>
   <span class="font10">reported </span>
   <span class="font10">study </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Group </span>
   <span class="font10">daily </span>
   <span class="font10">daysÂ </span>
   <span class="font10">potential </span>
   <span class="font10">activity </span>
   <span class="font10">disease </span>
   <span class="font10">first </span>
   <span class="font10">novel </span>
   <span class="font10">severe </span>
   <span class="font10">this </span>
   <span class="font10">twice </span>
   <span class="font10">Comparator: </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">RNA </span>
   <span class="font10">cases </span>
   <span class="font10">data </span>
   <span class="font10">therapeutic </span>
   <span class="font10">China </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">al., </span>
   <span class="font10">blind </span>
   <span class="font10">drugs </span>
   <span class="font10">into </span>
   <span class="font10">studies </span>
   <span class="font10">ACE </span>
   <span class="font10">April </span>
   <span class="font10">COVID-, </span>
   <span class="font10">SARS </span>
   <span class="font10">Severe </span>
   <span class="font10">can </span>
   <span class="font10">cells </span>
   <span class="font10">hospitalized </span>
   <span class="font10">risk </span>
   <span class="font10">used </span>
   <span class="font10">virus </span>
   <span class="font10">... </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Clinical </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Non-Randomized; </span>
   <span class="font10">Therapy </span>
   <span class="font10">effective </span>
   <span class="font10">syndrome </span>
   <span class="font10">transmission </span>
   <span class="font10">who </span>
   <span class="font10">y/o) </span>
   <span class="font10">â€" </span>
   <span class="font10">Efficacy </span>
   <span class="font10">Infect. </span>
   <span class="font10">Med. </span>
   <span class="font10">Plasma </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Single </span>
   <span class="font10">This </span>
   <span class="font10">WHO </span>
   <span class="font10">With </span>
   <span class="font10">antiviral </span>
   <span class="font10">being </span>
   <span class="font10">care </span>
   <span class="font10">development </span>
   <span class="font10">host </span>
   <span class="font10">immune </span>
   <span class="font10">improvement </span>
   <span class="font10">patients. </span>
   <span class="font10">rate </span>
   <span class="font10">received </span>
   <span class="font10">tablets </span>
   <span class="font10">than </span>
   <span class="font10">therapy </span>
   <span class="font10">Day </span>
   <span class="font10">However, </span>
   <span class="font10">LPV/r </span>
   <span class="font10">Not </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">Safety </span>
   <span class="font10">Tocilizumab </span>
   <span class="font10">Treatment </span>
   <span class="font10">acute </span>
   <span class="font10">agents </span>
   <span class="font10">any </span>
   <span class="font10">did </span>
   <span class="font10">efficacy </span>
   <span class="font10">every </span>
   <span class="font10">followed </span>
   <span class="font10">high </span>
   <span class="font10">human </span>
   <span class="font10">listed </span>
   <span class="font10">other </span>
   <span class="font10">over </span>
   <span class="font10">protein </span>
   <span class="font10">recovered </span>
   <span class="font10">results </span>
   <span class="font10">testing </span>
   <span class="font10">their </span>
   <span class="font10">via </span>
   <span class="font10">Applicable </span>
   <span class="font10">HCQ </span>
   <span class="font10">Syndrome </span>
   <span class="font10">Trial </span>
   <span class="font10">antibodies </span>
   <span class="font10">cells. </span>
   <span class="font10">convalescent </span>
   <span class="font10">entry </span>
   <span class="font10">evidence </span>
   <span class="font10">global </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">in-vitro </span>
   <span class="font10">more </span>
   <span class="font10">outbreak </span>
   <span class="font10">polymerase </span>
   <span class="font10">px; </span>
   <span class="font10">response </span>
   <span class="font10">safety </span>
   <span class="font10">such </span>
   <span class="font10">times </span>
   <span class="font10">two </span>
   <span class="font10">vitro </span>
   <span class="font10">without </span>
   <span class="font10">{font-family </span>
   <span class="font10">Acute </span>
   <span class="font10">Assignment;Open </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">December </span>
   <span class="font10">Disease </span>
   <span class="font10">Engl. </span>
   <span class="font10">Fig. </span>
   <span class="font10">Health </span>
   <span class="font10">Institute </span>
   <span class="font10">Study </span>
   <span class="font10">baseline </span>
   <span class="font10">days. </span>
   <span class="font10">doi:./.... </span>
   <span class="font10">due </span>
   <span class="font10">during </span>
   <span class="font10">font-size </span>
   <span class="font10">inhibitors </span>
   <span class="font10">protease </span>
   <span class="font10">rapidly </span>
   <span class="font10">recently </span>
   <span class="font10">retrospective </span>
   <span class="font10">severity </span>
   <span class="font10">spread </span>
   <span class="font10">therapies </span>
   <span class="font10">â€"Â </span>
   <span class="font10">Double </span>
   <span class="font10">Drug </span>
   <span class="font10">March </span>
   <span class="font10">Table </span>
   <span class="font10">There </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">adverse </span>
   <span class="font10">antibody </span>
   <span class="font10">around </span>
   <span class="font10">based </span>
   <span class="font10">benefit </span>
   <span class="font10">case </span>
   <span class="font10">clearance </span>
   <span class="font10">cohort </span>
   <span class="font10">conducted </span>
   <span class="font10">control </span>
   <span class="font10">dayÂ </span>
   <span class="font10">double; </span>
   <span class="font10">enzyme </span>
   <span class="font10">found </span>
   <span class="font10">health </span>
   <span class="font10">hospital </span>
   <span class="font10">impact </span>
   <span class="font10">improved </span>
   <span class="font10">inhibitor </span>
   <span class="font10">level </span>
   <span class="font10">mRNA </span>
   <span class="font10">might </span>
   <span class="font10">neutralizing </span>
   <span class="font10">outcomes </span>
   <span class="font10">potent </span>
   <span class="font10">recent </span>
   <span class="font10">receptor </span>
   <span class="font10">recovery </span>
   <span class="font10">reduce </span>
   <span class="font10">reduction </span>
   <span class="font10">repurposed </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">shown </span>
   <span class="font10">spike </span>
   <span class="font10">standard </span>
   <span class="font10">then </span>
   <span class="font10">time </span>
   <span class="font10">transfusion </span>
   <span class="font10">transfusionÂ </span>
   <span class="font10">type </span>
   <span class="font10">viruses </span>
   <span class="font10">within </span>
   <span class="font10">world </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">Antiviral; </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">Covid-, </span>
   <span class="font10">Elsevier </span>
   <span class="font10">IL- </span>
   <span class="font10">May </span>
   <span class="font10">References </span>
   <span class="font10">SOLIDARITY </span>
   <span class="font10">Sci. </span>
   <span class="font10">United </span>
   <span class="font10">across </span>
   <span class="font10">administration </span>
   <span class="font10">all </span>
   <span class="font10">approved </span>
   <span class="font10">arms </span>
   <span class="font10">associated </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">available </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">candidate </span>
   <span class="font10">capsules </span>
   <span class="font10">cell </span>
   <span class="font10">chloroquine </span>
   <span class="font10">completed </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">could </span>
   <span class="font10">current </span>
   <span class="font10">day, </span>
   <span class="font10">days) </span>
   <span class="font10">existing </span>
   <span class="font10">given </span>
   <span class="font10">had </span>
   <span class="font10">healthcare </span>
   <span class="font10">include </span>
   <span class="font10">individuals </span>
   <span class="font10">infected </span>
   <span class="font10">mg, </span>
   <span class="font10">mild </span>
   <span class="font10">oxygen </span>
   <span class="font10">patient </span>
   <span class="font10">period </span>
   <span class="font10">placebo </span>
   <span class="font10">public </span>
   <span class="font10">regimen </span>
   <span class="font10">research </span>
   <span class="font10">resource </span>
   <span class="font10">resulting </span>
   <span class="font10">significant </span>
   <span class="font10">solid; </span>
   <span class="font10">system </span>
   <span class="font10">table </span>
   <span class="font10">there </span>
   <span class="font10">those </span>
   <span class="font10">well </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Adverse </span>
   <span class="font10">August </span>
   <span class="font10">China, </span>
   <span class="font10">Chinese </span>
   <span class="font10">Contacts </span>
   <span class="font10">Covid- </span>
   <span class="font10">Current </span>
   <span class="font10">DNA </span>
   <span class="font10">Dexamethasone </span>
   <span class="font10">Diphosphate </span>
   <span class="font10">Diseases </span>
   <span class="font10">East </span>
   <span class="font10">HCQ/CQ </span>
   <span class="font10">HIV </span>
   <span class="font10">I/II </span>
   <span class="font10">Ill </span>
   <span class="font10">Inactivated </span>
   <span class="font10">Intervention: </span>
   <span class="font10">Middle </span>
   <span class="font10">National </span>
   <span class="font10">November </span>
   <span class="font10">Oral </span>
   <span class="font10">Quadruple </span>
   <span class="font10">Research </span>
   <span class="font10">Results </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">Ritonavir </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">These </span>
   <span class="font10">Time </span>
   <span class="font10">Triple </span>
   <span class="font10">Use </span>
   <span class="font10">about </span>
   <span class="font10">analysis </span>
   <span class="font10">bat </span>
   <span class="font10">before </span>
   <span class="font10">benefits </span>
   <span class="font10">best </span>
   <span class="font10">binds </span>
   <span class="font10">bold </span>
   <span class="font10">cardiovascular </span>
   <span class="font10">cause </span>
   <span class="font10">centre </span>
   <span class="font10">countries </span>
   <span class="font10">courier; </span>
   <span class="font10">damage </span>
   <span class="font10">different </span>
   <span class="font10">diseases </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">emerged </span>
   <span class="font10">enrolled </span>
   <span class="font10">epidemiological </span>
   <span class="font10">etc. </span>
   <span class="font10">experimental </span>
   <span class="font10">fasting </span>
   <span class="font10">help </span>
   <span class="font10">highly </span>
   <span class="font10">hourly </span>
   <span class="font10">humans </span>
   <span class="font10">ill </span>
   <span class="font10">increased </span>
   <span class="font10">infection </span>
   <span class="font10">infection, </span>
   <span class="font10">inhibits </span>
   <span class="font10">known </span>
   <span class="font10">lactoferrin </span>
   <span class="font10">less </span>
   <span class="font10">like </span>
   <span class="font10">limited </span>
   <span class="font10">mRNA-based </span>
   <span class="font10">management </span>
   <span class="font10">market </span>
   <span class="font10">may </span>
   <span class="font10">mg/kg </span>
   <span class="font10">monoclonal </span>
   <span class="font10">once </span>
   <span class="font10">options </span>
   <span class="font10">outcome </span>
   <span class="font10">overview </span>
   <span class="font10">patients, </span>
   <span class="font10">potentially </span>
   <span class="font10">preliminary </span>
   <span class="font10">prescribed </span>
   <span class="font10">present </span>
   <span class="font10">proven </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized </span>
   <span class="font10">receive </span>
   <span class="font10">regarding </span>
   <span class="font10">registered </span>
   <span class="font10">remains </span>
   <span class="font10">replication </span>
   <span class="font10">representation </span>
   <span class="font10">responses </span>
   <span class="font10">search </span>
   <span class="font10">seven </span>
   <span class="font10">several </span>
   <span class="font10">showed </span>
   <span class="font10">small </span>
   <span class="font10">some </span>
   <span class="font10">species </span>
   <span class="font10">specific </span>
   <span class="font10">start </span>
   <span class="font10">state. </span>
   <span class="font10">supportive </span>
   <span class="font10">swab </span>
   <span class="font10">therapy. </span>
   <span class="font10">they </span>
   <span class="font10">three </span>
   <span class="font10">through </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">total </span>
   <span class="font10">transfused </span>
   <span class="font10">treat </span>
   <span class="font10">treatmentÂ </span>
   <span class="font10">using </span>
   <span class="font10">vaccine. </span>
   <span class="font10">vaccines </span>
   <span class="font10">vector </span>
   <span class="font10">virus, </span>
  </p>
 </body>
</html>
